PF-06305591
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PF-06305591, covering 2013-05-23 to 2013-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of Multiple Doses of PF-06305591 [Phase 1]